Pediatr Gastroenterol Hepatol Nutr.  2019 Jul;22(4):303-329. 10.5223/pghn.2019.22.4.303.

Short Bowel Syndrome as the Leading Cause of Intestinal Failure in Early Life: Some Insights into the Management

• Goulet O
• Abi Nader
• Pigneur B
• Lambe C

• KMID: 2451572
• DOI: http://doi.org/10.5223/pghn.2019.22.4.303

Abstract

Intestinal failure (IF) is the critical reduction of the gut mass or its function below the minimum needed to absorb nutrients and fluids required for adequate growth in children. Severe IF requires parenteral nutrition (PN). Pediatric IF is most commonly due to congenital or neonatal intestinal diseases or malformations divided into 3 groups: 1) reduced intestinal length and consequently reduced absorptive surface, such as in short bowel syndrome (SBS) or extensive aganglionosis; 2) abnormal development of the intestinal mucosa such as congenital diseases of enterocyte development; 3) extensive motility dysfunction such as chronic intestinal pseudo-obstruction syndromes. The leading cause of IF in childhood is the SBS. In clinical practice the degree of IF may be indirectly measured by the level of PN required for normal or catch up growth. Other indicators such as serum citrulline have not proven to be highly reliable prognostic factors in children. The last decades have allowed the development of highly sophisticated nutrient solutions consisting of optimal combinations of macronutrients and micronutrients as well as guidelines, promoting PN as a safe and efficient feeding technique. However, IF that requires long-term PN may be associated with various complications including infections, growth failure, metabolic disorders, and bone disease. IF Associated Liver Disease may be a limiting factor. However, changes in the global management of IF pediatric patients, especially since the setup of intestinal rehabilitation centres did change the prognosis thus limiting "nutritional failure" which is considered as a major indication for intestinal transplantation (ITx) or combined liver-ITx.

Keyword

Intestinal failure; Parenteral nutrition; Short bowel syndrome; Serum citrulline; Intestinal failure associated liver disease; Intestinal rehabilitation centres; GLP-2 analogs; Home parenteral nutrition; Autologous bowel reconstruction; Intestinal transplantation

MeSH Terms

Bone Diseases
Child
Citrulline
Enterocytes
Humans
Intestinal Diseases
Intestinal Mucosa
Intestinal Pseudo-Obstruction
Liver Diseases
Micronutrients
Parenteral Nutrition
Parenteral Nutrition, Home
Prognosis
Rehabilitation
Short Bowel Syndrome*
Citrulline
Micronutrients

Figure

• 

  Fig. 1 Anatomy of short bowel causing intestinal failure in childhood. Classification of short bowel syndrome according to anatomy of the remnant intestine and different causes of intestinal resection. TIA: total intestinal aganglionosis, NEC: necrotizing enterocolitis.

• 

  Fig. 2 Consequences of SIBO. Consequences of overfeeding a dilated and poorly motile intestine leading to intestinal stasis, SIBO, mucosal injury, bacterial translocation, portal inflammation, cholestasis and fibrosis. SIBO: small intestinal bacterial overgrowth, ETF: enteral tube feeding.

• 

  Fig. 3 Autologous bowel surgery for short bowel syndrome. The LILT procedure and the STEP procedure. LILT: longitudinal tapering and lengthening, STEP: serial transverse enteroplasty.

Reference

1. Goulet O, Ruemmele F. Causes and management of intestinal failure in children. Gastroenterology. 2006; 130:S16–28.

2. Koletzko B, Goulet O, Hunt J, Krohn K, Shamir R, et al. Parenteral Nutrition Guidelines Working Group. 1. Guidelines on paediatric parenteral nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paediatric Research (ESPR). J Pediatr Gastroenterol Nutr. 2005; 41:Suppl 2. S1–S87.

3. Mihatsch W, Shamir R, van Goudoever JB, Fewtrell M, Lapillonne A, Lohner S, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: guideline development process for the updated guidelines. Clin Nutr. 2018; 37:2306–2308.

4. Abi Nader E, Lambe C, Talbotec C, Dong L, Pigneur B, Goulet O. A new concept to achieve optimal weight gain in malnourished infants on total parenteral nutrition. JPEN J Parenter Enteral Nutr. 2018; 42:78–86.

5. Crenn P, Coudray-Lucas C, Thuillier F, Cynober L, Messing B. Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology. 2000; 119:1496–1505.

6. Bailly-Botuha C, Colomb V, Thioulouse E, Berthe MC, Garcette K, Dubern B, et al. Plasma citrulline concentration reflects enterocyte mass in children with short bowel syndrome. Pediatr Res. 2009; 65:559–563.

7. Fragkos KC, Forbes A. Citrulline as a marker of intestinal function and absorption in clinical settings: a systematic review and meta-analysis. Eur J Gastroenterol. 2018; 6:181–191.

8. Abi Nader E, Lambe C, Talbotec C, Pigneur B, Lacaille F, Garnier-Lengliné H, et al. Outcome of home parenteral nutrition in 251 children over a 14-y period: report of a single center. Am J Clin Nutr. 2016; 103:1327–1336.

9. D'Antiga L, Goulet O. Intestinal failure in children: the European view. J Pediatr Gastroenterol Nutr. 2013; 56:118–126.

10. Goulet O, Joly F, Corriol O, Colomb-Jung V. Some new insights in intestinal failure-associated liver disease. Curr Opin Organ Transplant. 2009; 14:256–261.

11. Kaufman SS, Pehlivanova M, Fennelly EM, Rekhtman YM, Gondolesi GE, Little CA, et al. Predicting liver failure in parenteral nutrition-dependent short bowel syndrome of infancy. J Pediatr. 2010; 156:580–585.e1.

12. Pichler J, Horn V, Macdonald S, Hill S. Intestinal failure-associated liver disease in hospitalised children. Arch Dis Child. 2012; 97:211–214.

13. Goulet O, Lambe C. Intravenous lipid emulsions in pediatric patients with intestinal failure. Curr Opin Organ Transplant. 2017; 22:142–148.

14. Velazco CS, Fullerton BS, Brazzo JA 3rd, Hong CR, Jaksic T, Barnewolt CE. Radiographic measurement of intestinal length among children with short bowel syndrome: retrospective determination remains problematic. J Pediatr Surg. 2017; 52:1921–1924.

15. Weaver LT, Austin S, Cole TJ. Small intestinal length: a factor essential for gut adaptation. Gut. 1991; 32:1321–1323.

16. Struijs MC, Diamond IR, de Silva N, Wales PW. Establishing norms for intestinal length in children. J Pediatr Surg. 2009; 44:933–938.

17. Ricour C, Duhamel JF, Arnaud-Battandier F, Collard Y, Revillon Y, Nihoul-Fekete C. Enteral and parenteral nutrition in the short bowel syndrome in children. World J Surg. 1985; 9:310–315.

18. Goulet OJ, Revillon Y, Jan D, De Potter S, Maurage C, Lortat-Jacob S, et al. Neonatal short bowel syndrome. J Pediatr. 1991; 119:18–23.

19. Iacono G, Carroccio A, Montalto G, Cavataio F, Lo Cascio M, Notarbatolo A. Extreme short bowel syndrome: a case for reviewing the guidelines for predicting survival. J Pediatr Gastroenterol Nutr. 1993; 16:216–219.

20. Andorsky DJ, Lund DP, Lillehei CW, Jaksic T, Dicanzio J, Richardson DS, et al. Nutritional and other postoperative management of neonates with short bowel syndrome correlates with clinical outcomes. J Pediatr. 2001; 139:27–33.

21. Quirós-Tejeira RE, Ament ME, Reyen L, Herzog F, Merjanian M, Olivares-Serrano N, et al. Long-term parenteral nutritional support and intestinal adaptation in children with short bowel syndrome: a 25-year experience. J Pediatr. 2004; 145:157–163.

22. Goulet O, Baglin-Gobet S, Talbotec C, Fourcade L, Colomb V, Sauvat F, et al. Outcome and long-term growth after extensive small bowel resection in the neonatal period: a survey of 87 children. Eur J Pediatr Surg. 2005; 15:95–101.

23. Sala D, Chomto S, Hill S. Long-term outcomes of short bowel syndrome requiring long-term/home intravenous nutrition compared in children with gastroschisis and those with volvulus. Transplant Proc. 2010; 42:5–8.

24. Nusinovich Y, Revenis M, Torres C. Long-term outcomes for infants with intestinal atresia studied at Children's National Medical Center. J Pediatr Gastroenterol Nutr. 2013; 57:324–329.

25. Belza C, Fitzgerald K, de Silva N, Avitzur Y, Steinberg K, Courtney-Martin G, et al. Predicting intestinal adaptation in pediatric intestinal failure: a retrospective cohort study. Ann Surg. 2019; 269:988–993.

26. Khen-Dunlop N, Sarnacki S, Victor A, Grosos C, Menard S, Soret R, et al. Prenatal intestinal obstruction affects the myenteric plexus and causes functional bowel impairment in fetal rat experimental model of intestinal atresia. PLoS One. 2013; 8:e62292.

27. Urla C, Lieber J, Obermayr F, Busch A, Schweizer R, Warmann SW, et al. Surgical treatment of children with total colonic aganglionosis: functional and metabolic long-term outcome. BMC Surg. 2018; 18:58.

28. Goulet O, Olieman J, Ksiazyk J, Spolidoro J, Tibboe D, Köhler H, et al. Neonatal short bowel syndrome as a model of intestinal failure: physiological background for enteral feeding. Clin Nutr. 2013; 32:162–171.

29. Parvadia JK, Keswani SG, Vaikunth S, Maldonado AR, Marwan A, Stehr W, et al. Role of VEGF in small bowel adaptation after resection: the adaptive response is angiogenesis dependent. Am J Physiol Gastrointest Liver Physiol. 2007; 293:G591–G598.

30. Helmrath MA, Shin CE, Fox JW, Erwin CR, Warner BW. Adaptation after small bowel resection is attenuated by sialoadenectomy: the role for endogenous epidermal growth factor. Surgery. 1998; 124:848–854.

31. Olieman JF, Penning C, Ijsselstijn H, Escher JC, Joosten KF, Hulst JM, et al. Enteral nutrition in children with short-bowel syndrome: current evidence and recommendations for the clinician. J Am Diet Assoc. 2010; 110:420–426.

32. Cabrera-Rubio R, Collado MC, Laitinen K, Salminen S, Isolauri E, Mira A. The human milk microbiome changes over lactation and is shaped by maternal weight and mode of delivery. Am J Clin Nutr. 2012; 96:544–551.

33. Capriati T, Nobili V, Stronati L, Cucchiara S, Laureti F, Liguori A, et al. Enteral nutrition in pediatric intestinal failure: does initial feeding impact on intestinal adaptation? Expert Rev Gastroenterol Hepatol. 2017; 11:741–748.

34. Mezoff EA, Hawkins JA, Ollberding NJ, Karns R, Morrow AL, Helmrath MA. The human milk oligosaccharide 2′-fucosyllactose augments the adaptive response to extensive intestinal. Am J Physiol Gastrointest Liver Physiol. 2016; 310:G427–38.

35. de Boissieu D, Dupont C. Allergy to extensively hydrolyzed cow’s milk proteins in infants: safety and duration of amino acid-based formula. J Pediatr. 2002; 141:271–273.

36. Diamanti A, Fiocchi AG, Capriati T, Panetta F, Pucci N, Bellucci F, et al. Cow's milk allergy and neonatal short bowel syndrome: comorbidity or true association? Eur J Clin Nutr. 2015; 69:102–106.

37. Bines J, Francis D, Hill D. Reducing parenteral requirement in children with short bowel syndrome: impact of an amino acid-based complete infant formula. J Pediatr Gastroenterol Nutr. 1998; 26:123–128.

38. De Greef E, Mahler T, Janssen A, Cuypers H, Veereman-Wauters G. The influence of neocate in paediatric short bowel syndrome on PN weaning. J Nutr Metab. 2010; 2010:297575.

39. Norsa L, Lambe C, Abi Abboud S, Barbot-Trystram L, Ferrari A, Talbotec C, et al. The colon as an energy salvage organ for children with short bowel syndrome. Am J Clin Nutr. 2019; 109:1112–1118.

40. Tappenden KA, Thomson AB, Wild GE, McBurney MI. Short-chain fatty acid-supplemented total parenteral nutrition enhances functional adaptation to intestinal resection in rats. Gastroenterology. 1997; 112:792–802.

41. Bartholome AL, Albin DM, Baker DH, Holst JJ, Tappenden KA. Supplementation of total parenteral nutrition with butyrate acutely increases structural aspects of intestinal adaptation after an 80% jejunoileal resection in neonatal piglets. JPEN J Parenter Enteral Nutr. 2004; 28:210–222.

42. Reigstad CS, Salmonson CE, Rainey JF 3rd, Szurszewski JH, Linden DR, Sonnenburg JL, et al. Gut microbes promote colonic serotonin production through an effect of short-chain fatty acids on enterochromaffin cells. FASEB J. 2015; 29:1395–1403.

43. Koruda MJ, Rolandelli RH, Settle RG, Zimmaro DM, Rombeau JL. Effect of parenteral nutrition supplemented with short-chain fatty acids on adaptation to massive small bowel resection. Gastroenterology. 1988; 95:715–720.

44. Mayeur C, Gratadoux JJ, Bridonneau C, Chegdani F, Larroque B, Kapel N, et al. Faecal D/L lactate ratio is a metabolic signature of microbiota imbalance in patients with short bowel syndrome. PLoS One. 2013; 8:e54335.

45. Joly F, Mayeur C, Messing B, Lavergne-Slove A, Cazals-Hatem D, Noordine ML, et al. Morphological adaptation with preserved proliferation/transporter content in the colon of patients with short bowel syndrome. Am J Physiol Gastrointest Liver Physiol. 2009; 297:G116–23.

46. Kaneko T, Bando Y, Kurihara H, Satomi K, Nonoyama K, Matsuura N. Fecal microflora in a patient with short-bowel syndrome and identification of dominant lactobacilli. J Clin Microbiol. 1997; 35:3181–3185.

47. Engstrand Lilja H, Wefer H, Nyström N, Finkel Y, Engstrand L. Intestinal dysbiosis in children with short bowel syndrome is associated with impaired outcome. Microbiome. 2015; 3:18.

48. Davidovics ZH, Carter BA, Luna RA, Hollister EB, Shulman RJ, Versalovic J. The fecal microbiome in pediatric patients with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2016; 40:1106–1113.

49. Kadakia SC. D-lactic acidosis in a patient with jejunoileal bypass. J Clin Gastroenterol. 1995; 20:154–156.

50. Petersen C. D-lactic acidosis. Nutr Clin Pract. 2005; 20:634–645.

51. Hudson M, Pocknee R, Mowat NA. D-lactic acidosis in short bowel syndrome--an examination of possible mechanisms. Q J Med. 1990; 74:157–163.

52. Uchida H, Yamamoto H, Kisaki Y, Fujino J, Ishimaru Y, Ikeda H. D-lactic acidosis in short-bowel syndrome managed with antibiotics and probiotics. J Pediatr Surg. 2004; 39:634–636.

53. Takahashi K, Terashima H, Kohno K, Ohkohchi N. A stand-alone synbiotic treatment for the prevention of D-lactic acidosis in short bowel syndrome. Int Surg. 2013; 98:110–113.

54. Coronado BE, Opal SM, Yoburn DC. Antibiotic-induced D-lactic acidosis. Ann Intern Med. 1995; 122:839–842.

55. Husebye E. The patterns of small bowel motility: physiology and implications in organic disease and functional disorders. Neurogastroenterol Motil. 1999; 11:141–161.

56. Cole CR, Frem JC, Schmotzer B, Gewirtz AT, Meddings JB, Gold BD, et al. The rate of bloodstream infection is high in infants with short bowel syndrome: relationship with small bowel bacterial overgrowth, enteral feeding, and inflammatory and immune responses. J Pediatr. 2010; 156:941–947.e1.

57. Gutierrez IM, Kang KH, Calvert CE, Johnson VM, Zurakowski D, Kamin D, et al. Risk factors for small bowel bacterial overgrowth and diagnostic yield of duodenal aspirates in children with intestinal failure: a retrospective review. J Pediatr Surg. 2012; 47:1150–1154.

58. Quigley EMM. The spectrum of small intestinal bacterial overgrowth (SIBO). Curr Gastroenterol Rep. 2019; 21:3.

59. Triantafyllou K, Sioulas AD, Giamarellos-Bourboulis EJ. Rifaximin: the revolutionary antibiotic approach for irritable bowel syndrome. Mini Rev Med Chem. 2015; 16:186–192.

60. Rosania R, Giorgio F, Principi M, Amoruso A, Monno R, Di Leo A, et al. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol. 2013; 8:169–172.

61. Wales PW, de Silva N, Kim JH, Lecce L, Sandhu A, Moore AM. Neonatal short bowel syndrome: a cohort study. J Pediatr Surg. 2005; 40:755–762.

62. Squires RH, Duggan C, Teitelbaum DH, Wales PW, Balint J, Venick R, et al. Natural history of pediatric intestinal failure: initial report from the pediatric intestinal failure consortium. J Pediatr. 2012; 161:723–728.e2.

63. Hukkinen M, Mutanen A, Pakarinen MP. Small bowel dilation in children with short bowel syndrome is associated with mucosal damage, bowel-derived bloodstream infections, and hepatic injury. Surgery. 2017; 162:670–679.

64. Willis TC, Carter BA, Rogers SP, Hawthorne KM, Hicks PD, Abrams SA. High rates of mortality and morbidity occur in infants with parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 2010; 34:32–37.

65. Hukkinen M, Kivisaari R, Merras-Salmio L, Koivusalo A, Pakarinen MP. Small bowel dilatation predicts prolonged parenteral nutrition and decreased survival in pediatric short bowel syndrome. Ann Surg. 2017; 266:369–375.

66. Moseley RH. Sepsis and cholestasis. Clin Liver Dis. 2004; 8:83–94.

67. Jones A, Selby PJ, Viner C, Hobbs S, Gore ME, McElwain TJ. Tumour necrosis factor, cholestatic jaundice, and chronic liver disease. Gut. 1990; 31:938–939.

68. Geier A, Fickert P, Trauner M. Mechanisms of disease: mechanisms and clinical implications of cholestasis in sepsis. Nat Clin Pract Gastroenterol Hepatol. 2006; 3:574–585.

69. Hermans D, Talbotec C, Lacaille F, Goulet O, Ricour C, Colomb V. Early central catheter infections may contribute to hepatic fibrosis in children receiving long-term parenteral nutrition. J Pediatr Gastroenterol Nutr. 2007; 44:459–463.

70. Wagner M, Zollner G, Trauner M. New molecular insights into the mechanisms of cholestasis. J Hepatol. 2009; 51:565–580.

71. El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, et al. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology. 2012; 55:1518–1528.

72. McKenna S, Gossling M, Bugarini A, Hill E, Anderson AL, Rancourt RC, et al. Endotoxemia induces IκBβ/NF-κB-dependent endothelin-1 expression in hepatic macrophages. J Immunol. 2015; 195:3866–3879.

73. Colomb V, Jobert-Giraud A, Lacaille F, Goulet O, Fournet JC, Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2000; 24:345–350.

74. Cavicchi M, Beau P, Crenn P, Degott C, Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med. 2000; 132:525–532.

75. Clayton PT, Whitfield P, Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition. 1998; 14:158–164.

76. Forchielli ML, Bersani G, Tala S, Grossi G, Puggioli C, Masi M. The spectrum of plant and animal sterols in different oil-derived intravenous emulsions. Lipids. 2010; 45:63–71.

77. Wanten G, Beunk J, Naber A, Swinkels D. Tocopherol isoforms in parenteral lipid emulsions and neutrophil activation. Clin Nutr. 2002; 21:417–422.

78. Linseisen J, Hoffmann J, Lienhard S, Jauch KW, Wolfram G. Antioxidant status of surgical patients receiving TPN with an omega-3-fatty acid-containing lipid emulsion supplemented with alpha-tocopherol. Clin Nutr. 2000; 19:177–184.

79. Gura KM, Duggan CP, Collier SB, Jennings RW, Folkman J, Bistrian BR, et al. Reversal of parenteral nutrition-associated liver disease in two infants with short bowel syndrome using parenteral fish oil: implications for future management. Pediatrics. 2006; 118:e197–e201.

80. Cowles RA, Ventura KA, Martinez M, Lobritto SJ, Harren PA, Brodlie S, et al. Reversal of intestinal failure-associated liver disease in infants and children on parenteral nutrition: experience with 93 patients at a referral center for intestinal rehabilitation. J Pediatr Surg. 2010; 45:84–87.

81. Nandivada P, Fell GL, Gura KM, Puder M. Lipid emulsions in the treatment and prevention of parenteral nutrition-associated liver disease in infants and children. Am J Clin Nutr. 2016; 103:629S–634S.

82. Rayyan M, Devlieger H, Jochum F, Allegaert K. Short-term use of parenteral nutrition with a lipid emulsion containing a mixture of soybean oil, olive oil, medium-chain triglycerides, and fish oil: a randomized double-blind study in preterm infants. JPEN J Parenter Enteral Nutr. 2012; 36:81S–94S.

83. Tomsits E, Pataki M, Tölgyesi A, Fekete G, Rischak K, Szollár L, et al. Safety and efficacy of a lipid emulsion containing a mixture of soybean oil, medium-chain triglycerides, olive oil, and fish oil: a randomised, double-blind clinical trial in premature infants requiring parenteral nutrition. J Pediatr Gastroenterol Nutr. 2010; 51:514–521.

84. Deshpande G, Simmer K, Deshmukh M, Mori TA, Croft KD, Kristensen J. Fish oil (SMOFlipid) and olive oil lipid (Clinoleic) in very preterm neonates. J Pediatr Gastroenterol Nutr. 2014; 58:177–182.

85. Goulet O, Antébi H, Wolf C, Talbotec C, Alcindor LG, Corriol O, et al. A new intravenous fat emulsion containing soybean oil, medium-chain triglycerides, olive oil, and fish oil: a single-center, double-blind randomized study on efficacy and safety in pediatric patients receiving home parenteral nutrition. JPEN J Parenter Enteral Nutr. 2010; 34:485–495.

86. Muhammed R, Bremner R, Protheroe S, Johnson T, Holden C, Murphy MS. Resolution of parenteral nutrition-associated jaundice on changing from a soybean oil emulsion to a complex mixed-lipid emulsion. J Pediatr Gastroenterol Nutr. 2012; 54:797–802.

87. Anez-Bustillos L, Dao DT, Fell GL, Baker MA, Gura KM, Bistrian BR, et al. Redefining essential fatty acids in the era of novel intravenous lipid emulsions. Clin Nutr. 2018; 37:784–789.

88. Baker MA, Mitchell PD, O'Loughlin AA, Potemkin AK, Anez-Bustillos L, Dao DT, et al. Characterization of fatty acid profiles in infants with intestinal failure-associated liver disease. JPEN J Parenter Enteral Nutr. 2018; 42:71–77.

89. Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP, Wu J, Koletzko B, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: lipids. Clin Nutr. 2018; 37:2324–2336.

90. Charbit-Henrion F, Chardot C, Ruemmele F, Talbotec C, Morali A, Goulet O, et al. Anastomotic ulcerations after intestinal resection in infancy. J Pediatr Gastroenterol Nutr. 2014; 59:531–536.

91. Frémond ML, Viala J, Tréton X, Roy M, Berrebi D, Gottrand F, et al. Digestive perianastomotic ulcerations and Crohn's disease. J Crohns Colitis. 2014; 8:1624–1631.

92. Bianchi A. Intestinal loop lengthening--a technique for increasing small intestinal length. J Pediatr Surg. 1980; 15:145–151.

93. Kim HB, Lee PW, Garza J, Duggan C, Fauza D, Jaksic T. Serial transverse enteroplasty for short bowel syndrome: a case report. J Pediatr Surg. 2003; 38:881–885.

94. Sudan D, Thompson J, Botha J, Grant W, Antonson D, Raynor S, et al. Comparison of intestinal lengthening procedures for patients with short bowel syndrome. Ann Surg. 2007; 246:593–601.

95. Bianchi A, Morabito A. The dilated bowel: a liability and an asset. Semin Pediatr Surg. 2009; 18:249–257.

96. Modi BP, Javid PJ, Jaksic T, Piper H, Langer M, Duggan C, et al. First report of the international serial transverse enteroplasty data registry: indications, efficacy, and complications. J Am Coll Surg. 2007; 204:365–371.

97. Thompson J, Sudan D. Intestinal lengthening for short bowel syndrome. Adv Surg. 2008; 42:49–61.

98. Ramos-Gonzalez G, Kim HB. Autologous intestinal reconstruction surgery. Semin Pediatr Surg. 2018; 27:261–266.

99. Barrett M, Demehri FR, Ives GC, Schaedig K, Arnold MA, Teitelbaum DH. Taking a STEP back: assessing the outcomes of multiple STEP procedures. J Pediatr Surg. 2017; 52:69–73.

100. Oliveira C, de Silva N, Wales PW. Five-year outcomes after serial transverse enteroplasty in children with short bowel syndrome. J Pediatr Surg. 2012; 47:931–937.

101. Mutanen A, Barrett M, Feng Y, Lohi J, Rabah R, Teitelbaum DH, et al. Short bowel mucosal morphology, proliferation and inflammation at first and repeat STEP procedures. J Pediatr Surg. 2019; 54:511–516.

102. Ziegler MM, Royal RE, Brandt J, Drasnin J, Martin LW. Extended myectomy-myotomy. A therapeutic alternative for total intestinal aganglionosis. Ann Surg. 1993; 218:504–509.

103. Fusaro F, Morini F, Mutanen A, De Angelis P, Tambucci R, Capriati T, et al. Autologous intestinal reconstructive surgery in the management of total intestinal aganglionosis. J Pediatr Gastroenterol Nutr. 2019; 68:635–641.

104. Matarese LE, Abu-Elmagd K. Somatropin for the treatment of short bowel syndrome in adults. Expert Opin Pharmacother. 2005; 6:1741–1750.

105. Goulet O, Dabbas-Tyan M, Talbotec C, Kapel N, Rosilio M, Souberbielle JC, et al. Effect of recombinant human growth hormone on intestinal absorption and body composition in children with short bowel syndrome. JPEN J Parenter Enteral Nutr. 2010; 34:513–520.

106. Peretti N, Loras-Duclaux I, Kassai B, Restier-Miron L, Guimber D, Gottrand F, et al. Growth hormone to improve short bowel syndrome intestinal autonomy: a pediatric randomized open-label clinical trial. JPEN J Parenter Enteral Nutr. 2011; 35:723–731.

107. Wales PW, Nasr A, de Silva N, Yamada J. Human growth hormone and glutamine for patients with short bowel syndrome. Cochrane Database Syst Rev. 2010; CD006321.

108. Jeppesen PB. Gut hormones in the treatment of short-bowel syndrome and intestinal failure. Curr Opin Endocrinol Diabetes Obes. 2015; 22:14–20.

109. Wilhelm SM, Lipari M, Kulik JK, Kale-Pradhan PB. Teduglutide for the treatment of short bowel syndrome. Ann Pharmacother. 2014; 48:1209–1213.

110. Carter BA, Cohran VC, Cole CR, Corkins MR, Dimmitt RA, Duggan C, et al. Outcomes from a 12-week, open-label, multicenter clinical trial of teduglutide in pediatric short bowel syndrome. J Pediatr. 2017; 181:102–111.e5.

111. Ben Lulu S, Coran AG, Shehadeh N, Shamir R, Mogilner JG, Sukhotnik I. Oral insulin stimulates intestinal epithelial cell turnover following massive small bowel resection in a rat and a cell culture model. Pediatr Surg Int. 2012; 28:179–187.

112. Hamer HM, Jonkers DM, Bast A, Vanhoutvin SA, Fischer MA, Kodde A, et al. Butyrate modulates oxidative stress in the colonic mucosa of healthy humans. Clin Nutr. 2009; 28:88–93.

113. McMellen ME, Wakeman D, Longshore SW, McDuffie LA, Warner BW. Growth factors: possible roles for clinical management of the short bowel syndrome. Semin Pediatr Surg. 2010; 19:35–43.

114. Spencer AU, Neaga A, West B, Safran J, Brown P, Btaiche I, et al. Pediatric short bowel syndrome: redefining predictors of success. Ann Surg. 2005; 242:403–409.

115. Nucci A, Burns RC, Armah T, Lowery K, Yaworski JA, Strohm S, et al. Interdisciplinary management of pediatric intestinal failure: a 10-year review of rehabilitation and transplantation. J Gastrointest Surg. 2008; 12:429–435.

116. Sigalet D, Boctor D, Robertson M, Lam V, Brindle M, Sarkhosh K, et al. Improved outcomes in paediatric intestinal failure with aggressive prevention of liver disease. Eur J Pediatr Surg. 2009; 19:348–353.

117. Fullerton BS, Hong CR, Jaksic T. Long-term outcomes of pediatric intestinal failure. Semin Pediatr Surg. 2017; 26:328–335.

118. Merritt RJ, Cohran V, Raphael BP, Sentongo T, Volpert D, Warner BW, et al. Intestinal rehabilitation programs in the management of pediatric intestinal failure and short bowel syndrome. J Pediatr Gastroenterol Nutr. 2017; 65:588–596.

119. Totonelli G, Tambucci R, Boscarelli A, Hermans D, Dall'Oglio L, Diamanti A, et al. Pediatric intestinal rehabilitation and transplantation registry: initial report from a European Collaborative Registry. Eur J Pediatr Surg. 2018; 28:75–80.

120. Lambe C, Poisson C, Talbotec C, Goulet O. Strategies to reduce catheter-related bloodstream infections in pediatric patients receiving home parenteral nutrition: the efficacy of taurolidine-citrate prophylactic-locking. JPEN J Parenter Enteral Nutr. 2018; 42:1017–1025.

121. Kawano T, Kaji T, Onishi S, Yamada K, Yamada W, Nakame K, et al. Efficacy of ethanol locks to reduce the incidence of catheter-related bloodstream infections for home parenteral nutrition pediatric patients: comparison of therapeutic treatment with prophylactic treatment. Pediatr Surg Int. 2016; 32:863–867.

122. Smith JM, Weaver T, Skeans MA, Horslen SP, Harper AM, Snyder JJ, et al. OPTN/SRTR 2016 annual data report: intestine. Am J Transplant. 2018; 18:Suppl 1. 254–290.

123. Moreno Villares J, Galiano Segovia MJ, Marín Ferrer M. Changes in feeding behavior of patients who had received enteral nutrition during the 1st year of life. Nutr Hosp. 1998; 13:90–94.

124. Krom H, de Winter JP, Kindermann A. Development, prevention, and treatment of feeding tube dependency. Eur J Pediatr. 2017; 176:683–688.

125. Wilken M, Cremer V, Berry J, Bartmann P. Rapid home-based weaning of small children with feeding tube dependency: positive effects on feeding behaviour without deceleration of growth. Arch Dis Child. 2013; 98:856–861.

126. Hopkins J, Cermak SA, Merritt RJ. Oral feeding difficulties in children with short bowel syndrome: a narrative review. Nutr Clin Pract. 2017; 884533617707493.

127. Chiatto F, Coletta R, Aversano A, Warburton T, Forsythe L, Morabito A. Messy play therapy in the treatment of food aversion in a patient with intestinal failure: our experience. JPEN J Parenter Enteral Nutr. 2019; 43:412–418.

128. Leonberg BL, Chuang E, Eicher P, Tershakovec AM, Leonard L, Stallings VA. Long-term growth and development in children after home parental nutrition. J Pediatr. 1998; 132:461–466.

129. Olieman JF, Tibboel D, Penning C. Growth and nutritional aspects of infantile short bowel syndrome for the past 2 decades. J Pediatr Surg. 2008; 43:2061–2069.

130. Wu J, Tang Q, Feng Y, Huang J, Tao Y, Wang Y, et al. Nutrition assessment in children with short bowel syndrome weaned off parenteral nutrition: a long-term follow-up study. J Pediatr Surg. 2007; 42:1372–1376.

131. Kimura O, Ono S, Furukawa T, Higuchi K, Deguchi E, Iwai N. Management strategies for infants with total intestinal aganglionosis. J Pediatr Surg. 2009; 44:1564–1567.

132. Colomb V, Dabbas-Tyan M, Taupin P, Talbotec C, Révillon Y, Jan D, et al. Long-term outcome of children receiving home parenteral nutrition: a 20-year single-center experience in 302 patients. J Pediatr Gastroenterol Nutr. 2007; 44:347–353.

133. Gandullia P, Lugani F, Costabello L, Arrigo S, Calvi A, Castellano E, et al. Long-term home parenteral nutrition in children with chronic intestinal failure: a 15-year experience at a single Italian centre. Dig Liver Dis. 2011; 43:28–33.

134. Pironi L, Joly F, Forbes A, Colomb V, Lyszkowska M, Baxter J, et al. Long-term follow-up of patients on home parenteral nutrition in Europe: implications for intestinal transplantation. Gut. 2011; 60:17–25.

135. Wiskin AE, Cole C, Owens DR, Morgan M, Burge DM, Beattie RM. Ten-year experience of home parenteral nutrition in a single centre. Acta Paediatr. 2012; 101:524–527.

136. Lezo A, Capriati T, Spagnuolo MI, Lacitignola L, Goreva I, Di Leo G, et al. Paediatric home artificial nutrition in Italy: report from 2016 survey on behalf of artificial nutrition network of Italian Society for Gastroenterology, Hepatology and Nutrition (SIGENP). Nutrients. 2018; 10:E1311.

137. Barclay AR, Henderson P, Gowen H, Puntis J. BIFS collaborators. The continued rise of paediatric home parenteral nutrition use: implications for service and the improvement of longitudinal data collection. Clin Nutr. 2015; 34:1128–1132.

138. Petit LM, Girard D, Ganousse-Mazeron S, Talbotec C, Pigneur B, Elie C, et al. Weaning off prognosis factors of home parenteral nutrition for children with primary digestive disease. J Pediatr Gastroenterol Nutr. 2016; 62:462–468.

139. Diamanti A, Conforti A, Panetta F, Torre G, Candusso M, Bagolan P, et al. Long-term outcome of home parenteral nutrition in patients with ultra-short bowel syndrome. J Pediatr Gastroenterol Nutr. 2014; 58:438–442.

140. Ganousse-Mazeron S, Lacaille F, Colomb-Jung V, Talbotec C, Ruemmele F, Sauvat F, et al. Assessment and outcome of children with intestinal failure referred for intestinal transplantation. Clin Nutr. 2015; 34:428–435.

141. Hill S, Ksiazyk J, Prell C, Tabbers M, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: home parenteral nutrition. Clin Nutr. 2018; 37:2401–2408.

142. Sudan D, DiBaise J, Torres C, Thompson J, Raynor S, Gilroy R, et al. A multidisciplinary approach to the treatment of intestinal failure. J Gastrointest Surg. 2005; 9:165–176.

143. Torres C, Sudan D, Vanderhoof J, Grant W, Botha J, Raynor S, et al. Role of an intestinal rehabilitation program in the treatment of advanced intestinal failure. J Pediatr Gastroenterol Nutr. 2007; 45:204–212.

144. Beath S, Pironi L, Gabe S, Horslen S, Sudan D, Mazeriegos G, et al. Collaborative strategies to reduce mortality and morbidity in patients with chronic intestinal failure including those who are referred for small bowel transplantation. Transplantation. 2008; 85:1378–1384.

145. Javid PJ, Malone FR, Reyes J, Healey PJ, Horslen SP. The experience of a regional pediatric intestinal failure program: successful outcomes from intestinal rehabilitation. Am J Surg. 2010; 199:676–679.

146. Grant D, Abu-Elmagd K, Mazariegos G, Vianna R, Langnas A, Mangus R, et al. Intestinal transplant registry report: global activity and trends. Am J Transplant. 2015; 15:210–219.

147. Norsa L, Gupte G, Ramos Boluda E, Joly F, Corcos O, Pirenne J, et al. Life of patients 10 years after a successful pediatric intestinal transplantation in Europe. Am J Transplant. 2018; 18:1489–1493.

148. Pironi L, Forbes A, Joly F, Colomb V, Lyszkowska M, Van Gossum A, et al. Survival of patients identified as candidates for intestinal transplantation: a 3-year prospective follow-up. Gastroenterology. 2008; 135:61–71.

149. Pironi L, Hébuterne X, Van Gossum A, Messing B, Lyszkowska M, Colomb V, et al. Candidates for intestinal transplantation: a multicenter survey in Europe. Am J Gastroenterol. 2006; 101:1633–1643.

150. Pironi L, Goulet O, Buchman A, Messing B, Gabe S, Candusso M, et al. Outcome on home parenteral nutrition for benign intestinal failure: a review of the literature and benchmarking with the European prospective survey of ESPEN. Clin Nutr. 2012; 31:831–845.

151. Norsa L, Artru S, Lambe C, Talbotec C, Pigneur B, Ruemmele F, et al. Long term outcomes of intestinal rehabilitation in children with neonatal very short bowel syndrome: parenteral nutrition or intestinal transplantation. Clin Nutr. 2019; 38:926–933.

152. Taha AM, Sharif K, Johnson T, Clarke S, Murphy MS, Gupte GL. Long-term outcomes of isolated liver transplantation for short bowel syndrome and intestinal failure-associated liver disease. J Pediatr Gastroenterol Nutr. 2012; 54:547–551.

153. Sauvat F, Grimaldi C, Lacaille F, Ruemmele F, Dupic L, Bourdaud N, et al. Intestinal transplantation for total intestinal aganglionosis: a series of 12 consecutive children. J Pediatr Surg. 2008; 43:1833–1838.

154. Lacaille F, Irtan S, Dupic L, Talbotec C, Lesage F, Colomb V, et al. Twenty-eight years of intestinal transplantation in Paris: experience of the oldest European center. Transpl Int. 2017; 30:178–186.

155. Marschall J, Mermel LA, Fakih M, Hadaway L, Kallen A, O'Grady NP, et al. Strategies to prevent central line-associated bloodstream infections in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol. 2014; 35:753–771.

156. Goulet OJ. Intestinal failure-associated liver disease and the use of fish oil-based lipid emulsions. World Rev Nutr Diet. 2015; 112:90–114.

157. Abu-Elmagd K. The concept of gut rehabilitation and the future of visceral transplantation. Nat Rev Gastroenterol Hepatol. 2015; 12:108–120.